Depression, III: treatments.
Manji
Husseini
H
Maryland Psychiatric Research Center, University of Maryland, P.O. Box 21247, Baltimore, MD 21228, USA. ctamming@mprc.umaryland.edu
D000818:Animals; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000503:physiopathology; D001921:Brain / Q000187:drug effects* / Q000503:physiopathology; D019208:Brain-Derived Neurotrophic Factor / Q000502:physiology; D003866:Depressive Disorder / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000502:physiology; D051381:Rats; D015290:Second Messenger Systems / Q000187:drug effects* / Q000502:physiology
D000928:Antidepressive Agents; D019208:Brain-Derived Neurotrophic Factor; D018696:Neuroprotective Agents; D019253:Proto-Oncogene Proteins c-bcl-2